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Accepted 17 May 2013The mucopolysaccharidoses (MPS) are a group of rare inherited
lysosomal storage disorders. One subtype of type VI MPS, also
known asMaroteauxeLamy syndrome, is characterized by systemic
clinical manifestations with symptoms related to the skeletal, car-
diac, respiratory, ophthalmologic, and central and peripheral ner-
vous systems.
A 21-year-old female college student was diagnosed with MPS
type VI at 3 years of age and received weekly naglazyme replace-
ment therapy since she was 12 years old (Fig. 1). Thoracolumbar
spine radiography revealed ﬂattening of the vertebral bodies,
lumbar ﬂattening of the vertebral bodies, lumbar scoliosis with
bilateral dysplastic hips, and deformity of the femoral heads (Fig. 2).
Spinal stenosis of the second and third cervical vertebrae with
cervical cord compression and myelomalacia were noted on head
and cervical magnetic resonance imaging and at recent clinical
follow-up. Integrated care has been initiated but the main focus
was on the diverse spectrum of disease manifestations.
In order to offer more holistic clinical care, the patient’s psy-
chosocial status was assessed by a set of semistructured questions,
mixed with open-ended and closed questions focused on self-
identity, coping strategies for school life and the disease effects,
the patient’s vision of the meaning of life, and the expected roles of
friends and medical personnel. A 1-hour interview was scheduledFig. 1. Photograph of the patient. Note the coarse facial features, large head, frontal
bossing, thick eyebrows, depressed nasal bridge, full lips, short stature, and claw
hands. Reproduced with permission from the patient.
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Fig. 2. Thoracolumbar spinal radiograph. Note the oar-shaped ribs (ribs take off from
the vertebral bodies and broaden distally) and dysplastic vertebral bodies. Bilateral
dislocated hips and deformity of the femoral heads are also observed.
Vice chairperson of the student association at university
Devoted to people with special needs 
Volunteer at primary school student guidance department
Poor interpersonal and 
social skills
Unable to manage   
isolation and   
stigmatization from
others
Disease limitations
No normal social life
No intimate relationship
Restricted career growth  
Great support 
and participation 
from her mother
1. Healthcare and 
support from 
government and 
medical personnel
2. College preparation 
for her schooling
Poor self-esteem
Dysmorphic body features
Poor self image 
Personal core values
(sublimation mechanism)
Fig. 3. Results of interview. Black arrows indicate restricted and negative forces noted
from patient’s life experience. Purple arrows indicate supporting systems identiﬁed.
Red arrow: sublimation mechanism driving patient holding a positive personal core
value for altruistic behavior.
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tent analysis was done by three researchers and interpretation was
by consensus.
Self-awareness of the disease began at the age of 7 years because
of her short stature compared with that of her school-aged peers.
Most perceptions from schoolmates were negative. She felt inten-
tionally isolated from her peers and most of her teachers at school
prior to entering college. She accepted the unfriendly environment
silently. Her experience with healthcare professionals was satis-
factory. The physicians and medical personnel she encountered
were very friendly and supportive. She appreciated participating in
a Phase III clinical trial in England and received enzyme replace-
ment therapy free of charge in Taiwan. The patient seemed more
emotionally positive with other MPS patients and was an active
listener. Her mother was the most important support person in her
life.
She is clear about her intentions and understands her situation.
She cares about children, and studied subjects dealing with chil-
dren and the family in college. At school she strives to do her bestand tries to play an optimal role in class. She wants to be remem-
bered by society in some special way. She also wants an intimate
relationship. Searching for an identity from others is still a lifelong
issue for her, and she is afraid of death and refuses to face it (Fig. 3).
With the support of a sublimation mechanism, she holds a
positive personal core value for altruistic behavior despite three
negative forces from her life experience.
Generation of a friendly growth environment through public
education, continued psychological support, and generation of
adaptive life skills from early childhood are mandatory for people
with special needs.Further reading
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